Outlook Therapeutics (OTLK) Times Interest Earned: 2015-2020
Historic Times Interest Earned for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to -$526.18.
- Outlook Therapeutics' Times Interest Earned fell 771.37% to -$526.18 in Q3 2020 from the same period last year, while for Sep 2020 it was -$20.97, marking a year-over-year decrease of 100.31%. This contributed to the annual value of -$22.71 for FY2024, which is 8.22% down from last year.
- Per Outlook Therapeutics' latest filing, its Times Interest Earned stood at -$526.18 for Q3 2020, which was down 1,865.00% from -$26.78 recorded in Q2 2020.
- Outlook Therapeutics' Times Interest Earned's 5-year high stood at -$1.36 during Q3 2017, with a 5-year trough of -$526.18 in Q3 2020.
- Over the past 3 years, Outlook Therapeutics' median Times Interest Earned value was -$9.72 (recorded in 2020), while the average stood at -$62.13.
- Its Times Interest Earned has fluctuated over the past 5 years, first skyrocketed by 94.29% in 2017, then slumped by 771.37% in 2020.
- Quarterly analysis of 5 years shows Outlook Therapeutics' Times Interest Earned stood at -$36.38 in 2016, then soared by 87.82% to -$4.43 in 2017, then plummeted by 106.61% to -$9.15 in 2018, then tumbled by 49.63% to -$13.69 in 2019, then plummeted by 771.37% to -$526.18 in 2020.
- Its last three reported values are -$526.18 in Q3 2020, -$26.78 for Q2 2020, and -$9.72 during Q1 2020.